VRTX – The second-generation drug is not yet in human trials. All that was announced on the CC was the existence of a lead compound, which is not an item that required disclosure due to materiality.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”